300 related articles for article (PubMed ID: 26327255)
1. Mammography use and mode of detection among breast cancer patients in Estonia.
Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
[TBL] [Abstract][Full Text] [Related]
2. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
[TBL] [Abstract][Full Text] [Related]
3. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
4. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis.
Onitilo AA; Liang H; Stankowski RV; Engel JM; Broton M; Doi SA; Miskowiak DA
Rural Remote Health; 2014; 14(3):2738. PubMed ID: 25018129
[TBL] [Abstract][Full Text] [Related]
5. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.
Baburin A; Aareleid T; Padrik P; Valvere V; Innos K
Acta Oncol; 2014 Feb; 53(2):226-34. PubMed ID: 23767956
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
[TBL] [Abstract][Full Text] [Related]
7. Attending breast cancer screening alone does not explain the detection of tumours at an early stage.
Ouédraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
Eur J Cancer Prev; 2013 Mar; 22(2):103-11. PubMed ID: 22751208
[TBL] [Abstract][Full Text] [Related]
8. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.
Silva TB; Mauad EC; Carvalho AL; Jacobs LA; Shulman LN
Rural Remote Health; 2013; 13(2):2321. PubMed ID: 23597169
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
[TBL] [Abstract][Full Text] [Related]
10. Use of mammography and Pap smear in Estonia, a country without organized cancer screening.
Tekkel M; Veideman T; Baburin A; Rahu M
Int J Public Health; 2007; 52(2):109-16. PubMed ID: 18704290
[TBL] [Abstract][Full Text] [Related]
11. Proportion of women with self-reported opportunistic mammography before organized screening.
Heikkinen S; Miettinen J; Koskenvuo M; Huovinen R; Pitkäniemi J; Sarkeala T; Malila N
Acta Oncol; 2016 Jul; 55(7):865-9. PubMed ID: 27144814
[TBL] [Abstract][Full Text] [Related]
12. Place of residence predicts breast cancer stage at diagnosis in Estonia.
Innos K; Mägi M; Tekkel M; Aareleid T
Eur J Public Health; 2011 Jun; 21(3):376-80. PubMed ID: 20237172
[TBL] [Abstract][Full Text] [Related]
13. Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis Among DoD Beneficiaries.
Manjelievskaia J; Brown D; Shao S; Hofmann K; Shriver CD; Zhu K
Mil Med; 2017 Mar; 182(3):e1782-e1789. PubMed ID: 28290959
[TBL] [Abstract][Full Text] [Related]
14. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
[TBL] [Abstract][Full Text] [Related]
15. Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia.
Innos K; Padrik P; Valvere V; Eelma E; Kütner R; Lehtsaar J; Tekkel M
BMC Public Health; 2013 Oct; 13():947. PubMed ID: 24107190
[TBL] [Abstract][Full Text] [Related]
16. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
[TBL] [Abstract][Full Text] [Related]
17. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
18. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
[TBL] [Abstract][Full Text] [Related]
19. Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes.
Alenzi EO; Madhavan SS; Tan X
Breast Cancer Res Treat; 2018 Jan; 167(1):183-193. PubMed ID: 28866828
[TBL] [Abstract][Full Text] [Related]
20. Breast and cervical cancer screening in Spain and predictors of adherence.
Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]